Showing results (1-10 of 254) with videos related to
Sort By:
Pageof 26
The EPMA Journal|June 17, 2017
Pattern recognition for predictive, preventive, and personalized medicine in cancerTingting Cheng, Xianquan ZhanFrontiers in Endocrinology|June 16, 2016
Human Pituitary Adenoma Proteomics: New Progresses and PerspectivesXianquan Zhan, Xiaowei Wang, Tingting ChengFrontiers in Endocrinology|January 11, 2020
Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary AdenomasYing Long, Miaolong Lu, Tingting Cheng, et al.Frontiers in Endocrinology|January 11, 2020
Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the PatientsTingting Cheng, Ya Wang, Miaolong Lu, et al.The EPMA Journal|December 14, 2019
TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomasYa Wang, Tingting Cheng, Miaolong Lu, et al.Oxidative Medicine and Cellular Longevity|March 4, 2022
Machine Learning Identifies Pan-Cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related GenesNa Li, Xianquan ZhanThe EPMA Journal|August 28, 2020
Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicineNa Li, Xianquan ZhanMass Spectrometry Reviews|February 15, 2023
Mass spectrometry analysis of phosphotyrosine-containing proteinsJiajia Li, Xianquan ZhanOxidative Medicine and Cellular Longevity|May 2, 2022
Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian CancerLiang Shen, Xianquan ZhanMass Spectrometry Reviews|February 6, 2020
MASS SPECTROMETRY-BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERSNa Li, Xianquan ZhanPageof 26